The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter

Molecular and Cellular Biology

Volumn 18, Issue 12, 1998, Pages 7147-7156

  Vallian, Sadeq ^a   Chin, Khew Voon ^b   Chang, Kun Sang ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE; ONCOPROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; DROSOPHILA MELANOGASTER; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

ANIMALIA; DROSOPHILA MELANOGASTER; MAMMALIA; MELANOGASTER;

EID: 0031755628     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.12.7147     Document Type: Article

References (61)

1. Ahn, J.-H., and G. S. Hayward. 1997. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71:4599-4613.
2. Alcalay, M., L. Tomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Fagioli, L. Szekely, K. Helin, and P. G. Pelicci. 1998. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol. 18:1084-1093.
3. Ascoli, C. A., and G. G. Maul. 1991. Identification of a novel nuclear domain. J. Cell Biol. 112:785-795.
4. Bannister, A. J., and T. Kouzarides. 1995. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14:4758-4762.
5. Blake, M. C., and J. C. Azizkhan. 1989. Transcriptional factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9:4994-5002.
6. Boddy, M. N., K. Howe, L. D. Etkin, E. Solomon, and P. S. Freemont. 1996. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13:971-982.
7. Brown, D., S. Kogan, E. Lagasse, I. Weissman, M. Alcalay, P. G. Pelicci, S. Atwater, and J. M. Bishop. 1997. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94:2551-2556.
8. Carvalho, T., J.-S. Seeler, K. Ohman, P. Jordan, U. Pettersson, G. Akusjarvi, M. Carmo-Fonseca, and A. Dejean. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131:45-56.
9. Chang, K. S., Y. H. Fan, M. Andreeff, J. X. Liu, and Z. M. Mu. 1995. The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85:3646-3653.
10. Chang, K. S., S. A. Stass, D.-T. Chu, L. L. Deaven, J. M. Trujillo, and E. J. Freireich. 1992. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol. Cell. Biol. 12:800-810.
11. Chen, L. I., T. Nishinaka, K. Kwan, I. Kitabayashi, K. Yokoyama, Y.-H. Fu, S. Grünwald, and R. Chiu. 1994. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14:4380-4389.
12. Datta, P. K., P. Raychaudhuri, and S. Bagchi. 1995. Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription. Mol. Cell. Biol. 15:5444-5452.
13. Ded, S. P., R. M. Munoz, D. R. Brown, M. A. Subler, and D. Sumitra. 1994. Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9:1341-1349.
14. de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARalpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
15. Doucas, V., and R. M. Evans. 1996. The PML nuclear component and cancer. Biochim. Biophys. Acta 1288:M25-M29.
16. Dyck, J. A., G. G. Maul, W. H. Miller, J. D. Chen, A. Kakizuka, and R. M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
17. Everett, R. D., and G. G. Maul. 1994. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13:5062-5069.
18. Freemont, P. S., I. M. Hanson, and J. Trowsdale. 1991. A novel cystein-rich sequence motif. Cell 64:483-484.
19. Goddard, A. D., J. Borrow, P. S. Freemont, and E. Solomon. 1991. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254:1371-1374.
20. Gongora, D., G. David, L. Pintard, C. Tissot, T. D. Hua, A. Dejean, and N. Mechti. 1997. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272:19457-19463.
21. Gregory, R. C., D. J. Taxman, D. Seshasayee, M. H. Kensinger, J. J. Bieker, and D. M. Wojchowski. 1996. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood 87:1793-1801.
22. Grisolano, J. L., R. L. Wesselschmidt, P. G. Pelicci, and T. J. Ley. 1997. Altered myeloid development and acute leukemia in transgenic mice expressing PMLRARa under control of catapsin G regulatory sequences. Blood 89:376-387.
23. Gualberto, A., and A. S. Baldwin, Jr. 1995. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J. Biol. Chem. 270:19680-19683.
24. Guiochon-Mantel, A., F. J. Savouret, F. Quignon, K. Delaber, E. Milgrom, and H. De The. 1995. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 9:1791-1803.
25. He, D., Z.-M. Mu, X. Le, J.-T. Hsieh, R.-C. Pong, L. W. K. Chung, and K.-S. Chang. 1997. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res. 57:1868-1872.
26. He, L. Z., C. Tribioli, R. Rivi, D. Peruzzi, P. G. Pelicci, V. Soares, G. Cattoretti, and P. P. Pandolphi. 1997. Acute leukemia with promyelocytic features in PMLRARalpha transgenic mice. Proc. Natl. Acad. Sci. USA 94:5302-5307.
27. Hudson, L. G., J. B. Santon, and G. N. Gill. 1989. Regulation of epidermal growth factor receptor gene expression. Mol. Endocrinol. 3:400-408.
28. Ishii, S., Y.-H. Xu, R. H. Stratton, B. A. Roe, G. T. Merlino, and I. Pastan. 1985. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. USA 82:4920-4924.
29. Ishov, A. M., R. Stenberg, and G. G. Maul. 1997. Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J. Cell Biol. 138:5-16.
30. Jensen, D., A. R. Black, A. Swick, and J. C. Azizkhan. 1997. Distinct role for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J. Cell. Biochem. 67:24-31.
31. Johnson, A. C., S. Ishii, Y. Jinno, I. Pastan, and G. T. Merlino. 1988. Epidermal growth factor receptor gene promoter. J. Biol. Chem. 263:5693-5699.
32. Johnson, D., J. Schwarz, W. Cress, and J. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
33. Kadonaga, J. T., A. J. Courey, J. Ladika, and R. Tjian. 1988. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 242: 1566-1570.
34. Kageyama, R., G. T. Merlino, and I. Pastan. 1988. Epidermal growth factor (EGF) receptor gene transcription. J. Biol. Chem. 263:6329-6336.
35. Kakizuka, A., W. H. J. Miller, K. Umesono, R. P. J. Warrell, S. R. Frankel, V. V. V. S. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARalpha with a novel putative transcription factor, PML. Cell 66:663-674.
36. Karlseder, J., H. Rotheneder, and E. Wintersberger. 1996. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1659-1667.
37. Kastner, P., A. Perez, Y. Lutz, C. Rochette Egly, M. P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon. 1992. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11:629-642.
38. Kennett, S. B., A. J. Udvadia, and J. M. Horowitz. 1997. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25:3110-3117.
39. Koken, M. H. M., G, Linares Cruz, F. Quignon, A. Viron, M. K. Chelbi Alix, J. Sobczak Thepot, L. Juhlin, L. Degos, F. Calvo, and H. De Thé. 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315-1324.
40. Koken, M. H. M., A. Reid, F. Quignon, M. K. Chelbi-Alix, J. M. Davies, J. H. S. Kabarowski, J. Zhu, S. Dong, S.-J. Chen, Z. Chen, C. C. Tan, J. Licht, S. Waxman, H. De Thé, and A. Zelent. 1997. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Natl. Acad. Sci. USA 94:10255-10260.
41. Kumar, A. P., and A. P. Butler. 1997. Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1. Nucleic Acids Res. 25:2012-2019.
42. LaMorte, V. J., J. A. Dyck, R. L. Ochs, and R. M. Evans. 1998. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95:4991-4996.
43. Le, X.-F., S. Vallian, Z.-M. Mu, M.-C. Hung, and K.-S. Chang. 1998. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16:1839-1849.
44. Le, X. F., P. Yang, and K. S. Chang. 1996. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML: J. Biol. Chem. 271:130-135.
45. Lee, J.-S., K. M. Galvin, and Y. Shi. 1993. Evidence for physical interaction between the zinc-finger transcription factor YY1 and Sp1. Proc. Natl. Acad. Sci. USA 90:6145-6149.
46. Lin, S.-Y., A. R. Black, D. Kostic, S. Pajovic, C. N. Hoover, and J. C. Azizkhan. 1996. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol. 16:1668-1675.
47. Liu, J. H., Z. M. Mu, and K. S. Chang. 1995. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181:1965-1973.
48. Morishige, K.-I., H. Kurachi, K. Amemiya, Y. Fujita, T. Yamamoto, A. Miyake, and O. Tanizawa. 1991. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res. 51:5322-5328.
49. Mu, Z.-M., X.-F. Le, S. Vallian, A. B. Glassman, and K.-S. Chang. 1997. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18:2063-2069.
50. Mu, Z.-M., K.-V. Chin, J.-H. Liu, G. Lozano, and K.-S. Chang. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14:6858-6867.
51. Mukhopadhyay, D., B. Knebelmann, H. T. Cohen, S. Ananth, and V. P. Sukhatme. 1997. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol. 17:5629-5639.
52. Noe, V., C. Chen, C. Alemany, M. Nicolas, I. Caragol, L. Chasin, and C. Ciudad. 1997. Cell-growth regulation of the hamster dihydrofolate reductase gene promoter by transcription factor Sp1. Eur. J. Biochem. 249:13-20.
53. Szekely, L., K. Pokrovskaja, W.-Q. Jiang, H. de Thé, N. Ringertz, and G. Klein. 1996. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol. 70:2562-2568.
54. Toi, M., A. Osaki, H. Yamada, and T. Toge. 1991. Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. Eur. J. Cancer 27:977-980.
55. Udvadia, A. J., K. T. Rogers, P. D. Higgins, Y. Murata, K. H. Martin, P. A. Humphrey, and J. M. Horowitz. 1993. Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc. Natl. Acad. Sci. USA 90:3265-3269.
56. Udvadia, A. J., D. J. Templeton, and J. M. Horowitz. 1995. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc. Natl. Acad. Sci. USA 92:3953-3957.
57. Vallian, S., A. J. Gaken, E. B. Gingold, T. Kouzarides, K.-S. Chang, and F. Farzaneh. 1998. Modulation of Fos-mediated AP1 transcription by the promyelocytic leukemia protein. Oncogene 16:2843-2853.
58. Vallian, S., A. J. Gaken, I. D. Trayner, E. B. Gingold, T. Kouzarides, K.-S. Chang, and F. Farzaneh. 1997. Transcriptional repression by the promyelocytic leukemia protein. PML. Exp. Cell Res. 237:371-382.
59. Wang, Z. G., L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld, and P. P. Pandolfi. 1998. Role of PML in cell growth and the retinoic acid pathway. Science 279:1547-1551.
60. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RARalpha in acute promyelocytic leukemia cells. Cell 76:345-356.
61. Xu, J., K. L. Thompson, L. B. Shephard, L. G. Hudson, and G. N. Gill. 1993. T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. J. Biol. Chem. 268:16065-16073.